Reports for MAGNESIUM SULFATE INJECTION, USP
Brand name
MAGNESIUM SULFATE INJECTION, USP
Company Name
FRESENIUS KABI CANADA LTD
|
Drug Identification Number
02139499 |
Ingredients
MAGNESIUM SULFATE |
Ingredient Strength
500 MG |
ATC Code
B05XAB05XA B05XA |
ATC Descriptor
I.V. SOLUTION ADDITIVES I.V. SOLUTION ADDITIVES I.V. SOLUTION ADDITIVES |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| MAGNESIUM SULFATE INJECTION, USP | 10mL | Resolved | 2018-05-30 | 2018-10-25 | 50924 |
| MAGNESIUM SULFATE INJECTION, USP | 50mL | Resolved | 2018-05-30 | 2018-10-25 | 50929 |
| MAGNESIUM SULFATE INJECTION, USP | 500 mg/mL, SD Vial, 50 mL | Resolved | 2020-11-05 | 2021-01-26 | 127839 |
| MAGNESIUM SULFATE INJECTION, USP | 50 mL | Resolved | 2021-03-29 | 2022-12-15 | 136534 |
| MAGNESIUM SULFATE INJECTION, USP | 10 mL | Resolved | 2021-03-30 | 2022-05-01 | 136555 |
| MAGNESIUM SULFATE INJECTION, USP | 10mL | Resolved | 2022-04-22 | 2023-01-20 | 159333 |
| MAGNESIUM SULFATE INJECTION, USP | 50 ML | Actual shortage | 2024-01-31 | 2024-02-03 | 217935 |
Showing 1 to 7 of 7
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0